TCF7L1 Antibody - N-terminal region

Artikelnummer: ASB-ARP30092_P050
Artikelname: TCF7L1 Antibody - N-terminal region
Artikelnummer: ASB-ARP30092_P050
Hersteller Artikelnummer: ARP30092_P050
Alternativnummer: ASB-ARP30092_P050-25UL,ASB-ARP30092_P050-100UL
Hersteller: Aviva
Wirt: Rabbit
Kategorie: Proteine/Peptide
Applikation: IHC, WB
Spezies Reaktivität: Bovine, Canine, Guinea pig, Human, Mouse, Rat
Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human TCF7L1
Alternative Synonym: TCF3, TCF-3
TCF7L1 participates in the Wnt signaling pathway. It binds to DNA and acts as a repressor in the absence of CTNNB1, and as an activator in its presence. It is necessary for the terminal differentiation of epidermal cells, the formation of keratohyalin granules and the development of the barrier function of the epidermis. TCF7L1 down-regulates NQO1, leading to increased mitomycin c resistance.
Klonalität: Polyclonal
Konzentration: 0.5 mg/ml
Molekulargewicht: 63kDa
NCBI: 83439
UniProt: Q9HCS4
Formulierung: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
25 ug of the indicated Human whole cell extracts was loaded onto a 12% SDS-PAGE gel. 3 ug/mL of the antibody was used in this experiment.
Immunohistochemistry with Human Skin lysate tissue at an antibody concentration of 5.0ug/ml using anti-TCF7L1 antibody (ARP30092_P050)
WB Suggested Anti-TCF7L1 Antibody Titration: 0.2-1 ug/ml
ELISA Titer: 1:312500
Positive Control: 293T cell lysate
TCF7L1 antibody - N-terminal region (ARP30092_P050) in Human 293T using Western Blot